- Price is above the Trend Line, keeping the weekly tape constructive.
- Activity pressure is positive on the latest completed week.
EMBLA
CPH
Week ended 07 Aug 2026
Weekly Investor Report
Embla Medical hf · Healthcare · Medical Devices
Latest close
29.35 DKK
3.7%
latest week
Weekly setup
Mixed setup
The weekly trend is not active. Price is 4.1% above the Trend Line and sits at 33.7% of its 52-week range. The latest completed week returned 3.7%, after a 11.8% four-week move. The latest news-sentiment score is 53/100.
Setup score
50
out of 100
Latest Close
29.35 DKK
7 Aug 2026
1W Return
3.7%
latest completed week
4W Return
11.8%
short-term follow-through
12W Return
11.8%
quarterly tape
Trend Breadth
36.5%
19 of 52 weeks active
Volume Ratio
1.0x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Activity pressure is weak, so confirmation is not yet broad enough.
- The share remains more than 20% below its 52-week high.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
3.7%
Latest completed week; four-week move 11.8%.
Indicator stack
20/100
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Recent
Activity-pressure buy-signal status for institutional accumulation timing.
News sentiment
53/100
37 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is 4.1% above the Trend Line and sits at 33.7% of its 52-week range. The latest completed week returned 3.7%, after a 11.8% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.0x the 13-week average. Participation is around or above normal and provides reasonable confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.2712-week average 0.21
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure9/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.27Current proprietary activity-pressure read.
Buy signals3Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 11.8% over four weeks, 11.8% over 12 weeks, and -3.1% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year19
Trend breadth36.5%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.86Latest activity-pressure read.
Pressure change730.0%Four-week change in activity pressure.
Leadership-7.52Latest relative-leadership reading.
RS change61.8%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment53/100
Weighted news tone is neutral across 37 relevant articles.
7 positive · 30 neutral · 0 negativePatient CapitalRecent
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
Recent buy signal in the last 8 weeks
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-22.6%Distance below the 52-week high.
13-week volatility2.6%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher12 of 2613 weeks finished lower.
Best week+6.2%Week of 24 Jul.
Worst week-6.8%Week of 13 Mar.
Latest week+3.7%Week of 7 Aug.
Shape of recent returns
Strong gains2
Modest gains10
Flat weeks1
Modest losses10
Sharp losses3
Recent vol2.6%13-week weekly-return volatility.
Base vol4.3%52-week weekly-return volatility.
Up/down split21/29Count of positive and negative weeks in the 52-week window.
Average skew3.9% / -2.8%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorDK Healthcare
4-week rank4 / 21
Group average4.0%
Trend breadth28.6%
Trend28.6%active weekly trend signals
MD66.7%positive activity pressure
RS14.3%positive relative leadership
Four-week leaders
IndustryDK Medical Devices
4-week rank1 / 7
Group average5.5%
Trend breadth14.3%
Trend14.3%active weekly trend signals
MD85.7%positive activity pressure
RS14.3%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape45/100
Trend, activity pressure, participation, and risk combine to a 45/100 tape read.
Indicator analysis29/100Latest 12-week confirmation: trend 0/12, activity pressure 9/12, relative leadership 0/12.
Activity pressure 0.27; No reversal markers Factors50/100No published factor snapshot is available yet.
Patient CapitalRecentActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
Recent buy signal in the last 8 weeks Sentiment53/100Weighted news tone is neutral across 37 relevant articles.
Embla Medical hf: Transactions in relation to Share Buyback Program Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 29.35 DKK | 3.7% | 28.18 DKK | 30.68 DKK | 0.86 | -7.52 | 306.2K | Off |
| 31 Jul 2026 | 28.30 DKK | 0.5% | 28.30 DKK | 30.69 DKK | 0.52 | -10.81 | 325.6K | Off |
| 24 Jul 2026 | 28.15 DKK | 6.2% | 28.42 DKK | 30.71 DKK | 0.31 | -11.22 | 589.3K | Off |
| 17 Jul 2026 | 26.50 DKK | 1.0% | 28.58 DKK | 30.73 DKK | 0.07 | -19.78 | 375.0K | Off |
| 10 Jul 2026 | 26.25 DKK | -2.4% | 28.82 DKK | 30.77 DKK | 0.10 | -19.66 | 211.3K | Off |
| 3 Jul 2026 | 26.90 DKK | 1.9% | 29.06 DKK | 30.81 DKK | 0.10 | -19.15 | 77.0K | Off |
| 26 Jun 2026 | 26.40 DKK | -0.9% | 29.39 DKK | 30.84 DKK | 0.04 | -16.97 | 38.4K | Off |
| 19 Jun 2026 | 26.65 DKK | -0.2% | 29.77 DKK | 30.88 DKK | 0.11 | -13.91 | 42.9K | Off |
| 12 Jun 2026 | 26.70 DKK | -2.7% | 30.01 DKK | 30.92 DKK | 0.03 | -15.43 | 19.2K | Off |
| 5 Jun 2026 | 27.45 DKK | -0.4% | 30.25 DKK | 30.95 DKK | -0.11 | -12.68 | 210.0K | Off |
| 29 May 2026 | 27.55 DKK | 2.2% | 30.49 DKK | 30.97 DKK | -0.28 | -14.03 | 1.2M | Off |
| 22 May 2026 | 26.95 DKK | 2.7% | 30.69 DKK | 30.99 DKK | -0.54 | -16.23 | 453.5K | Off |
| 15 May 2026 | 26.25 DKK | -3.5% | 30.92 DKK | 31.01 DKK | -0.62 | -17.77 | 237.6K | Off |
| 8 May 2026 | 27.20 DKK | 1.7% | 31.07 DKK | 31.04 DKK | -0.49 | -13.93 | 312.3K | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.